ketanserin has been researched along with Mitral Incompetence in 1 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| van der Starre, PJ | 1 |
| Solinas, C | 1 |
1 other study available for ketanserin and Mitral Incompetence
| Article | Year |
|---|---|
Ketanserin in the treatment of protamine-induced pulmonary hypertension.
Topics: Aged; Coronary Artery Bypass; Heart Valve Prosthesis; Heparin Antagonists; Humans; Hypertension, Pul | 1996 |